O
Oriza
Oriza is a Series A to Series D stage investment firm. It has made 9 investments. 33% of their portfolio is in Biotech & Life Sciences. Average disclosed round size is $59.7M (across 4 rounds with reported amounts).
Portfolio
9
Fund Size
—
Top Stage
Series B
Last 12 Mo
0
Team
FJ
Fei Jianjiang
Founder, General Manager & Managing Partner
KL
Kong Lingguo
Founder
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
9 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| EEluminex Biosciences | Series B | — | Feb 2023 |
 Elpiscience | Series C | $105M | May 2021 |
| YYikon Genomics | Unknown | $38.7M | Jan 2021 |
| CCROSSBAR, INC. | Series D | $35M | — |
 Neurophth | Series B | — | — |
 Minova Pharma | Series A | — | — |
 Chilye | Series C | — | — |
| 迈迈诺威医药 | Series A | — | — |
| 克克睿基因 | Series B | $60M | — |
Top Co-Investors
Northern Light Venture Capital2 shared
LAV2 shared
LYZZ Capital2 shared
Tyche Partners1 shared
Korea Investment Partners1 shared
SAIF Partners1 shared
University of Michigan1 shared
Correlation Ventures1 shared
3E Bioventures Capital1 shared
Sequoia China1 shared
Pivotal Life Sciences1 shared
IDG Capital1 shared
Xiaomi1 shared
Cormorant Asset Management1 shared
Dyee Capital1 shared
CDH Investments1 shared
Lilly Asia Ventures1 shared
WuXi Healthcare Ventures1 shared
Yunfeng Capital1 shared
Last updated: 8 September 2026